DAMORA THERAPEUTICS, INC. Option Contract Indexed To Equity Settlement Share Fair Value
DAMORA THERAPEUTICS, INC. (DMRA) had Option Contract Indexed To Equity Settlement Share Fair Value of $9.53 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes
us-gaap:OptionContractIndexedToEquitySettlementShareFairValue · last filed 2026-08-10
- 2026-06-30: Option Contract Indexed To Equity Settlement Share Fair Value $9.53M.
- 2026-03-31: Option Contract Indexed To Equity Settlement Share Fair Value $4.98M.
- 2025-12-31: Option Contract Indexed To Equity Settlement Share Fair Value $0.00.
| Period end | Option Contract Indexed To Equity Settlement Share Fair Value |
|---|---|
| 2026-06-30 | $9.53M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $4.98M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |